Understand Your Health with the Diag Cancer Screening Panels

Comprehensive cancer screening for men and women
Detection of breast, lung, colorectal, prostate and stomach cancers
Supports diagnosis, treatment monitor, recurrence detection
Simple, time-efficient, receive online results
Variety of individual tests, customizable based on needs

Cancer screening tests are conducted to detect potential tumor markers. Test results can be used for screening and assisting in diagnosing cancer at various stages of the disease. In many cases, cancer screening tests are needed to monitor treatment efficiency and detect disease recurrence.

Adults over 50 years old
Individuals with a family history of cancer
Individuals who regularly use stimulants
Individuals currently undergoing cancer treatment
Smokers or individuals who live with a smoker
People with cirrhosis, hepatitis and other liver diseases
Those suspected of having breast cancer, colorectal cancer, etc.

Cyfra 21-1 (Cytokeratin 19)

A cancer marker valuable in monitoring non-small cell lung cancer (NSCLC) when combined with CEA and SCC, as well as other cancers like bladder cancer. CYFRA 21-1 is released into the blood during the breakdown of these cancer cells.

Thyroglobulin

Thyroglobulin is a protein produced by the thyroid gland. This test is primarily used for monitoring but does not help in diagnosing well-differentiated thyroid cancer patients. Measuring thyroglobulin levels after thyroidectomy or radioiodine ablation helps in detecting metastases. Additionally, the test aids in diagnosing hyperthyroidism and hypothyroidism - common non-cancerous thyroid conditions.

Alpha-Fetoprotein (AFP)*

A tumor marker often produced by cancer cells or normal cells in response to cancer. Elevated AFP levels can indicate liver, ovarian, or testicular cancer, though other non-cancerous conditions can also increase AFP levels.

CA 19-9

A quantitative test aimed at screening for abnormalities related to the pancreas and bile ducts.

Carcinoembryonic Antigen (CEA)

Abnormal levels of CEA may indicate cancer. Smoking can also increase CEA levels. This test is useful for monitoring response to treatment and checking for recurrence of colon, medullary thyroid, rectal, lung, breast, liver, pancreatic, stomach, and ovarian cancers.

Squamous cell carcinoma (SCC)

Squamous cells are a type of cell found on the skin's surface, lining the hollow organs of the body, and on the respiratory and digestive tract mucosa. Squamous cell carcinoma (SCC) of the skin is the second most common form of skin cancer, characterized by abnormal and excessive proliferation of these cells. The test helps in assessing and monitoring squamous cell carcinoma in the head and neck, lungs, and cervix.

Total Prostate-specific Antigen (Total PSA)*

PSA is a protein produced by the prostate gland. The test is used for screening but does not provide a definitive diagnosis of prostate cancer. Screening means looking for cancer signs before symptoms appear. If PSA results suggest cancer, additional tests are required to make a definite diagnosis and assess the extent of prostate cancer.

CA 125

Aids in early detection of ovarian cancer in individuals at very high risk. CA-125 levels may also increase in some non-cancerous conditions, such as uterine fibroids. Cancers that can elevate CA 125 levels include ovarian, endometrial, peritoneal, and fallopian tube cancers.

CA 15-3

CA 15-3 is a protein mostly produced by breast cancer cells. CA 15-3 values help in prognosis and assessing the severity of breast cancer. Higher CA 15-3 levels suggest more serious breast cancer.

HPV40 & Sample Self-Collection Kit

HPV is short for human papillomavirus, a very common sexually transmitted infection divided into different types, each identified with a number. HPV types including 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68 are high-risk types known to significantly increase the risk of cervical, vaginal, and vulvar cancer in women, as well as penile cancer in men. These types can also cause anal cancer and throat cancers in men and women.

Instant Health Advice, Complete Privacy

Online Consultancy

Instant health advice and booking via Zalo or Facebook

Full Privacy – Private Results

Your results and information remain strictly confidential

Diag Is Always Near You

Over 40+ locations throughout Ho Chi Minh City

View Locations

Blood Tests at Home – Easy & Comfortable

50,000+

Patients served at home

95%

Repeat customers

Frequently Asked Questions

1. What types of tests are performed for Cancer Screening Panels at Diag?

Customers only undergo blood tests to screen for cancer markers when performed at Diag.

2. What should be prepared before cancer screening tests?

Men: Avoid sexual activity, including masturbation and vigorous exercise, for at least 48 hours before sample collection. Avoid prostate examination/massage, ultrasound or catheterization for 10 days before sample collection. Women: No special preparation is needed.

3. Which cancers can be detected by the Cancer Screening Panels at Diag?

Diag’s Cancer Screening Panels can detect cancers of the breast, liver, lung, stomach, bladder, colon, rectum, thyroid, pancreas, prostate, testicles, ovaries, endometrium, peritoneum and fallopian tubes. SCC test helps evaluate and monitor squamous cell carcinoma of the head, neck, lung, and cervix.

4. Is cancer screening included in the Diag Wellness Checkup Panels?

The Diag Wellness Checkup Panels do not include cancer screening. However, customers can add cancer screening tests when registering for Wellness Checkup Panels at Diag.

5. Are cancer markers hereditary?

Not all cancer markers are hereditary. Non-hereditary cancer markers: AFP, CYFRA 21-1, CEA, CA 19-9, SCC, CA 15-3. Hereditary cancer markers: Thyroglobulin, Total PSA, CA 125.

6. Can cancer screening tests detect cancer early?

Yes, cancer screening tests can help detect certain cancers at an early stage, potentially before symptoms appear. However, testing needs to be in conjunction with other diagnostic tools.

7. What do elevated tumor marker levels mean?

Elevated tumor marker levels can indicate the presence of cancer, but they can also be elevated due to non-cancerous conditions. Further testing is required to determine the cause.

8. Can I have normal tumor marker levels and still have cancer?

If the levels of tumor markers are normal, you can still have cancer. Cancer screening tests are one of many tools used in cancer detection and management.

9. How long does it take to get cancer screening test results at Diag?

Cancer Screening Men Panel:
- If Diag's lab receives the sample before 9:30 PM (Mon - Sat) or before 8:30 PM (Sun), test results will be available after 2 hours and 30 minutes on the same day.
- If Diag's lab receives the sample after 9:30 PM (Mon - Sat) or after 8:30 PM (Sun), test results will be available at 9:00 AM the next day.

Cancer Screening Women Panel - Basic:
- If Diag's lab receives the sample before 9:30 PM (Mon - Sat) or before 8:30 PM (Sun), test results will be available after 2 hours and 30 minutes on the same day.
- If Diag's lab receives the sample after 9:30 PM (Mon - Sat) or after 8:30 PM (Sun), test results will be available at 9:00 AM the next day.

Cancer Screening Women Panel - Advanced:
- If Diag's lab receives the sample before 10:00 AM (Mon - Sun), test results will be available at 5:00 PM on the same day.
- If Diag's lab receives the sample after 10:00 AM (Mon - Sun), test results will be available the next day.

Understand Your Health with the Diag Cancer Screening Panels